MonitorPlan n/a · Option n/aWatch before adding
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETF
Mirae Asset Mutual FundExchange Traded Funds (ETFs) - Equity ETF2.7 years
- NAV
- 45.6285
- 30 Oct 2026
- 1Y
- -1.2%
- Trailing CAGR
- AUM
- ₹929.33 Cr
- 30 Jun 2026
- Volatility
- High
- 20.9% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Risk-adjusted return (Sharpe) is negative over the available daily history.
Prefer peers if · Prefer Aditya Birla Sun Life Nifty Healthcare ETF if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Fail
2.7 years - thin for judging consistency.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -30.5%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.
Browse category
Same-category peers are preloaded into compare when available.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 30%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y-1.2%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+0.6%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+5.4%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +0.6%
- Calendar-day CAGR
- Excess 1Y
- +4.9%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -30.5%
- Worst peak-to-trough
- Current
- -15.5%
- Below last peak
- Current spell
- 774 days
- Days below latest peak
- Time below peak
- +96%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 11 days
- 8 recovered episodes
- Longest recovery
- 41 days
- Trough to prior peak
16 Sept 2024 – open
Trough 23 Mar 2026 · not recovered
-30.5%
27 Feb 2024 – 3 Apr 2024
Trough 13 Mar 2024 · recovered in 21 days
-11.5%
30 Jul 2024 – 16 Sept 2024
Trough 6 Aug 2024 · recovered in 41 days
-7.9%
26 Apr 2024 – 7 Jun 2024
Trough 4 Jun 2024 · recovered in 3 days
-7.6%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
20
Vs category
81
Consistency
18
Risk-adjusted
18
Drawdown
24
Mean
32
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Monitor
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
- Risk-adjusted return (Sharpe) is negative over the available daily history.
Supporting reads
No supporting reads in the current evidence set.
No holdings or recent changes on file for this scheme yet.
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Aditya Birla Sun Life Nifty Healthcare ETF
Aditya Birla Sun Life Mutual Fund
- 1Y
- +11.3%
- 3Y
- +21.5%
- Vol
- 15.0%
- Max DD
- -18.3%
- Sharpe
- 0.59
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Axis NIFTY Bank ETF
Axis Mutual Fund
- 1Y
- -5.4%
- 3Y
- +8.9%
- Vol
- 18.1%
- Max DD
- -20.6%
- Sharpe
- 0.44
- 3Y win
- +32%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Zerodha Nifty Smallcap 100 ETF
Zerodha Mutual Fund
- 1Y
- +0.7%
- 3Y
- n/a
- Vol
- 18.4%
- Max DD
- -18.1%
- Sharpe
- -0.06
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Higher trailing returns
Mirae Asset BSE 200 Equal Weight ETF
Mirae Asset Mutual Fund
- 1Y
- -5.5%
- 3Y
- n/a
- Vol
- 15.2%
- Max DD
- -13.6%
- Sharpe
- 0.16
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Lower trailing returns
Mirae Asset Nifty Next 50 ETF
Mirae Asset Mutual Fund
- 1Y
- -2.6%
- 3Y
- +16.4%
- Vol
- 19.3%
- Max DD
- -36.0%
- Sharpe
- 0.48
- 3Y win
- +99%
- Lower volatility
- Higher win rate vs category
- Higher trailing returns
Caveat: Deeper drawdown